ben_ouyang Profile Banner
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ Profile
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ

@ben_ouyang

Followers
3K
Following
13K
Media
458
Statuses
3K

Biomedical engineer-turned physician, in pursuit of questions, answers, and all things curious. @danafarber. @mghmedres. @UofTMDPhD. @TheChanLab.

Toronto, Ontario
Joined September 2012
Don't wanna be here? Send us removal request.
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
1 month
RT @jitcancer: New #JITC short report: Tumor location as a risk factor for severe immune-related adverse events @sm….
0
2
0
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
1 month
RT @NEJM: Presented at #ASCO25: . Among patients with relapsed small-cell lung cancer after the failure of platinum-based chemotherapy, ta….
0
32
0
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
1 month
A walk a day keeps the cancer away.
@NEJM
NEJM
1 month
Presented at #ASCO25: . A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results:
Tweet media one
0
0
2
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
2 months
RT @davidrliu: In a medical milestone, a customized base editor was developed, characterized in human and mouse cells, tested in mice, stud….
0
433
0
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
2 months
RT @TheChanLab: 🚨New Paper 🚨. Bram et al. identified how nanoparticle charge interfaces with the cellular glycocalyx, dramatically affectin….
0
4
0
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
3 months
RT @Harvard: β€œNo governmentβ€”regardless of which party is in powerβ€”should dictate what private universities can teach, whom they can admit….
0
31K
0
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
1 year
RT @uoftmdphd: This year's MD/PhD Mentorship Symposium was a tremendous successβ€”an afternoon full of good learning and counselling 🀝 Thank….
0
6
0
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
1 year
RT @TheChanLab: 🚨🚨New Paper🚨🚨. Ever wonder where EPR came from?πŸ‘€. Matt et al. describe the history and evidence for the EPR effect and its….
0
16
0
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
2 years
RT @ThePoonLab: πŸ€”β“ Ever wondered how comparing nanoparticle delivery metrics across different studies is like comparing πŸŽπŸ†šπŸŠ? Check out our….
0
5
0
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
2 years
RT @wilsonpoon: Belated post, but had the best time hosting @ben_ouyang in El Paso last weekend! πŸ€©πŸœοΈπŸš— From local eats to seasonal views, th….
0
1
0
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
2 years
RT @fbouchard: 'The letter calls on @cafreeland to boost the funds available through the fed granting agencies in the fall economic stateme….
0
43
0
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
2 years
RT @Samir_Grover: How to doctor - a thread.
0
482
0
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
2 years
We're just asking to be comfortableβ€οΈπŸ‡¨πŸ‡¦ @CIHR_IRSC @NSERC_CRSNG @SSHRC_CRSH.
@CAN_ACN
CAN ACN
2 years
Why Canada is losing the next generation of researchers. With support for graduate students at a breaking point, Canadian universities are feeling the impact.
0
0
10
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
2 years
RT @wilsonpoon: πŸ“’ My department is hiring *2+ tenure-track position(s) this year! Come be my colleague at @UTEP ! I'm happy to answer any q….
0
4
0
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
2 years
RT @DrJonLim: 🚨 The latest @myESMO 🀝 @ASCO Recommendations for a Global Curriculum in Medical Oncology - Edition 2023 is now out! . Great t….
0
9
0
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
2 years
ESMO/ASCO 2023 global curriculum guidelines seem very useful for any trainee to build a foundation at the beginning of any new onc rotation #esmo23
0
0
0
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
2 years
Incredible results at #esmo23! ADCs delivering on the past promises of the nanoparticle field. β€œActive targeting” alive and well!.
@tompowles1
Tom Powles
2 years
Enfortumab vedotin & Pembrolizumab improving PFS & OS by 55% & 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%). Chemo has not been beaten before (despite multiple efforts). RR and CR of 68% & 29% is hard to beat. DOR not reached (1/3)#ESMO2023
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
0
9
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
2 years
Live at #ESMO2023! Come by our poster #2234 to learn more about tumours and irAEs!. (The answer is yes πŸ˜‰)
Tweet media one
1
0
66
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
2 years
A role model physician scientist signing a copy of the paper that pulled me to @mghmedres. Thank you for everything that you’ve done for us and the program over your 9 year tenure @jmvyasmdphd!
Tweet media one
0
0
67
@ben_ouyang
Ben Ouyang πŸ‘¨β€πŸ”¬πŸ‘¨β€βš•οΈ
2 years
RT @jmvyasmdphd: After 9 years, I have decided to step down as Program Director for the @MGHMedicine Residency. I am so grateful for the pr….
0
22
0